Breaking news on life science and diagnostics business, policy, and funding
The bill aims to reduce barriers to the use of genetic and genomic testing, including for children on Medicaid with a suspected genetic disease.
London-based LGC said that the acquisition increases its exposure to the next-generation sequencing and gene editing markets.
The test is based on the company's GARD platform for measuring genetic biomarkers of immune reactions to predict chemical sensitivities.
Among Flatiron's assets is a database developed in collaboration with Foundation Medicine intended to help biopharma firms develop more effective cancer therapies.
The investment bank gave the company's stock an Outperform rating with a target price of $90 per share.
A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.
Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.
In Science this week: CRISPR-based approach for recording cellular events, and more.
A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.